Daniela Maier

Ask VT AI

View News Summary

Istanbul meeting aims to shore up fragile Gaza ceasefire amid renewed violence.
Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.
Philips reports strong Q3 results, projects robust 2025 margins despite ongoing challenges.

20 days

United States Politics

Discover the latest news, candidates,  and key topics of US politics

Ask VT AI

View News Summary

Istanbul meeting aims to shore up fragile Gaza ceasefire amid renewed violence.
Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.
Philips reports strong Q3 results, projects robust 2025 margins despite ongoing challenges.

20 days

United States Politics

Discover the latest news, candidates,  and key topics of US politics

Most Reported By
News from Daniela Maier